US Weekly on MSN
Andy Richter Credits GLP-1 for ‘Dancing With the Stars’ Weight Loss: ‘Zepbound Helped a Lot’
Andy Richter got real about his Dancing With the Stars weight loss, attributing part of his slimdown to taking GLP-1 ...
You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...
President Donald Trump says Americans could soon pay far less for GLP-1 medications used for diabetes, obesity, and heart ...
Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...
Brooks Nader has kept it candid when it comes to her use of weight-loss drugs. The Sports Illustrated Swimsuit model has been ...
Patients with type 2 diabetes who use GLP-1 receptor agonists have a significantly lower risk for lung cancer than those who ...
Medpage Today on MSN
Investigational GLP-1-Based Drug Hits MASH Resolution Mark, Misses Fibrosis Target
WASHINGTON -- Treatment with the investigational GLP-1/glucagon dual receptor agonist pemvidutide led to resolution of ...
As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
Drugs like Ozempic, known collectively as GLP-1 receptor agonists, have become more widely used in recent years. Though they ...
This powerful serum taps the power of proxylane, a synethetic sugar derivative that mimics the effects of the natural sugars ...
At a time when insurers are backing away from coverage for weight loss medications, President Trump has offered a lifeline ...
Medpage Today on MSN
GLP-1 Use Prior to Pregnancy Tied to Lower Gestational Diabetes Risk
ATLANTA -- Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results